Your browser doesn't support javascript.
loading
Unmasking the biological function and regulatory mechanism of NOC2L: a novel inhibitor of histone acetyltransferase.
Lu, Siyi; Chen, Zhaoyu; Liu, Zhenzhen; Liu, Zhentao.
Afiliación
  • Lu S; Department of General Surgery, Peking University Third Hospital, Beijing, 100191, China.
  • Chen Z; Department of Basic Medical Sciences, Peking University Health Science Center, Beijing, 100191, China.
  • Liu Z; Department of Thoracic Surgery, Beijing Jishuitan Hospital, Beijing, 100035, China. liuzhenzhen2017@bjmu.edu.cn.
  • Liu Z; Department of Medical Oncology and Radiation Sickness, Peking University Third Hospital, Beijing, 100191, China. lztjmw@163.com.
J Transl Med ; 21(1): 31, 2023 01 17.
Article en En | MEDLINE | ID: mdl-36650543
ABSTRACT
NOC2 like nucleolar associated transcriptional repressor (NOC2L) was recently identified as a novel inhibitor of histone acetyltransferase (INHAT). NOC2L is found to have two INHAT function domains and regulates histone acetylation in a histone deacetylases (HDAC) independent manner, which is distinct from other INHATs. In this review, we summarize the biological function of NOC2L in histone acetylation regulation, P53-mediated transcription, ribosome RNA processing, certain development events and carcinogenesis. We propose that NOC2L may be explored as a potential biomarker and a therapeutic target in clinical practice.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Represoras / Histonas / Histona Acetiltransferasas Tipo de estudio: Prognostic_studies Idioma: En Revista: J Transl Med Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Represoras / Histonas / Histona Acetiltransferasas Tipo de estudio: Prognostic_studies Idioma: En Revista: J Transl Med Año: 2023 Tipo del documento: Article País de afiliación: China